GLIMEPIRIDE Side Effects

7015391-5 | Arteriosclerosis
on Sep 16, 2010 Male patient from UNITED STATES , 60 years of age, weighting 192.7 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis. Glimepiride dosage: 4 Mg, Per Oral. During the same period patient was treated with PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PLAVIX (View Plavix Review and Plavix Label ), TRICOR (ADENOSINE) (View Tricor (adenosine) Review and Tricor (adenosine) Label ), NIASPAN ER (NICOTINIC ACID) (View Niaspan Er (nicotinic Acid) Review and Niaspan Er (nicotinic Acid) Label ), RAMIPRIL (CAPSULES) (RAMIPRIL) (View Ramipril (capsules) (ramipril) Review and Ramipril (capsules) (ramipril) Label ). Patient was hospitalized.

7014318-X | Bladder Cancer, Lung Neoplasm
Patient was taking Glimepiride (View Usage). Patient had the following side effects: bladder cancer (What is bladder cancer?), lung neoplasm on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 208.0 lb, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: 4 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with LOTENSIN (View Lotensin Review and Lotensin Label ), NORVASC (View Norvasc Review and Norvasc Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6994680-4 | Blood Pressure Increased, Chest Pain, Fibula Fracture, Haematocrit Decreased, Haemoglobin Decreased, Lens Dislocation, Ocular Hyperaemia, Pain In Extremity, Retinal Injury
Adverse event was reported on Aug 31, 2010 by a Female patient taking Glimepiride (View Usage) (Dosage: 4 Mg, 1 In 1 D, Per Oral, 4 Mg, 1 In 1 D, Per Oral, 2 Mg, 2 In 1 D, Per Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 62 years of age, weighting 145.8 lb, After Glimepiride was administered, patient had the following side effects: blood pressure increased, chest pain (What is chest pain?), fibula fracture, haematocrit decreased, haemoglobin decreased, lens dislocation, ocular hyperaemia, pain in extremity, retinal injury. During the same period patient was treated with METFORMIN HCL (500 M G, 2 In 1 D, Per Oral, 500 Mg, 2 In 1 D, Per Oral, 500 Mg, 2 In 1 D, Per Oral) (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DARVOCET N (PROPACET) (View Darvocet N (propacet) Review and Darvocet N (propacet) Label ). Patient was hospitalized.

6992633-3 | Cerebrovascular Accident
on Sep 12, 2010 Female patient from UNITED STATES , 77 years of age, was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Glimepiride dosage: .


6971491-7 | Dehydration, Dizziness, Fluid Intake Reduced, Hyperhidrosis, Hypotension, Renal Failure Acute
on Aug 31, 2010 Male patient from UNITED STATES , 62 years of age, weighting 205.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: dehydration, dizziness (What is dizziness?), fluid intake reduced, hyperhidrosis, hypotension, renal failure acute. Glimepiride dosage: 4 Mg, 1 In 1 D, Oral. During the same period patient was treated with METFORMIN HCL (850 Mg, 2 In 1 D, Oral, 1000 Mg, 2 In 1 D, Oral, 1000 Mg, 2 In 1 D, Oral) (View Metformin Hcl Review and Metformin Hcl Label ), GUANFACINE HYDROCHLORIDE (View Guanfacine Hydrochloride Review and Guanfacine Hydrochloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), SOMA (View Soma Review and Soma Label ). Patient was hospitalized.

6964920-6 | Abdominal Pain, Abdominal Tenderness, Crohn's Disease, Diarrhoea
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal tenderness, crohn's disease (What is crohn's disease?), diarrhoea on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with hypothyroidism and. Glimepiride dosage: . During the same period patient was treated with METFORMIN (1 Tablet) (View Metformin Review and Metformin Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6964110-7 | Accidental Exposure, Hypoglycaemia, Unresponsive To Stimuli
Adverse event was reported on Aug 23, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: Two 4mg Tablets) was diagnosed with diarrhoea and. Location: AUSTRALIA , 82 years of age, Patient experienced the following unwanted or unexpected effects: accidental exposure, hypoglycaemia, unresponsive to stimuli. Patient was hospitalized.

6955887-5 | Abdominal Discomfort, Anorectal Disorder, Anxiety, Constipation, Crying, Diarrhoea, Dyspepsia, Gastrointestinal Pain, Irritability
on Aug 26, 2010 Female patient from UNITED STATES , 39 years of age, weighting 260.0 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: abdominal discomfort, anorectal disorder, anxiety (What is anxiety?), constipation (What is constipation?), crying, diarrhoea, dyspepsia, gastrointestinal pain, irritability. Glimepiride dosage: 4mg 2/daily Po.

6954952-6 | Accidental Exposure, Hypoglycaemia
on Aug 16, 2010 Male patient from AUSTRALIA , 82 years of age, was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: accidental exposure, hypoglycaemia. Glimepiride dosage: 8 Mg, Unk. Patient was hospitalized.

6938434-3 | Blood Bilirubin Increased, Hepatic Enzyme Increased, Jaundice Cholestatic, Pancreatitis Acute
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic enzyme increased, jaundice cholestatic, pancreatitis acute on Aug 18, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 61 years of age, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6936720-4 | Bladder Neoplasm
Adverse event was reported on Aug 11, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: 4 Mg, 1 In 1 D, Per Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 80 years of age, weighting 208.0 lb, Patient had the following side effects: bladder neoplasm. During the same period patient was treated with LOTENSIN (View Lotensin Review and Lotensin Label ), NORVASC (View Norvasc Review and Norvasc Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6934141-1 | Crohn's Disease
on Aug 16, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with hypothyroidism and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: crohn's disease (What is crohn's disease?). Glimepiride dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6917166-1 | Glomerulonephritis, Tubulointerstitial Nephritis
on Aug 05, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: glomerulonephritis, tubulointerstitial nephritis. Glimepiride dosage: .

6917154-5 | Crohn's Disease
Patient was taking Glimepiride (View Usage). Patient had the following side effects: crohn's disease (What is crohn's disease?) on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with hypothyroidism and. Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6908049-1 | Cardiac Failure Congestive, Dyspnoea, Oedema, Respiratory Failure, Sick Sinus Syndrome, Weight Increased
Adverse event was reported on Jul 26, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 62 years of age, After Glimepiride was administered, patient had the following side effects: cardiac failure congestive, dyspnoea, oedema, respiratory failure, sick sinus syndrome, weight increased. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6884683-2 | Arteriosclerosis
on Jul 19, 2010 Male patient from UNITED STATES , 60 years of age, weighting 192.7 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis. Glimepiride dosage: 4 Mg, Per Oral. During the same period patient was treated with PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PLAVIX (View Plavix Review and Plavix Label ), TRICOR (ADENOSINE) (View Tricor (adenosine) Review and Tricor (adenosine) Label ), NIASPAN (View Niaspan Review and Niaspan Label ). Patient was hospitalized.

6878421-7 | Adenocarcinoma Pancreas, Liver Function Test Abnormal
on Jul 20, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: adenocarcinoma pancreas, liver function test abnormal. Glimepiride dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6862181-X | Shock Hypoglycaemic
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: shock hypoglycaemic on Jul 14, 2010 from GERMANY Additional patient health information: Female patient , 78 years of age, weighting 119.0 lb, was diagnosed with type 2 diabetes mellitus, aortic arteriosclerosis, restless legs syndrome, hypertension, metastatic renal cell carcinoma, depression (What is depression?) and. Glimepiride dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), BLOPRESS PLUS (View Blopress Plus Review and Blopress Plus Label ), IBUPROFEN (1 Df Dosage Form) (View Ibuprofen Review and Ibuprofen Label ), MOLSIDOMINE (1 Df Dosage Form In Day) (View Molsidomine Review and Molsidomine Label ), MADOPAR (100 Mg Levodopa And 25 Mg Benserazide) (View Madopar Review and Madopar Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), VALORON N (View Valoron N Review and Valoron N Label ). Patient was hospitalized.

6826462-8 | Fatigue, Neck Mass, Throat Tightness, Thyroid Adenoma, Upper Respiratory Tract Congestion
Adverse event was reported on Jul 01, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, neck mass, throat tightness, thyroid adenoma, upper respiratory tract congestion. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6811509-5 | Confusional State, Delirium, Hypoglycaemic Unconsciousness, Pressure Of Speech
on Jun 07, 2010 Male patient from INDIA , 69 years of age, was diagnosed with diabetes mellitus, antifungal treatment, evidence based treatment and was treated with Glimepiride (View Usage). Patient had the following side effects: confusional state, delirium, hypoglycaemic unconsciousness, pressure of speech. Glimepiride dosage: 1 Mg Od, Oral. During the same period patient was treated with VORICONAZOLE (400 Mg X 2 200 Mg 2x/day, Oral) (View Voriconazole Review and Voriconazole Label ).

6809497-0 | Adrenal Adenoma, Cyst, Gastric Cyst, Oesophageal Disorder, Pancreatic Pseudocyst, Pancreatitis, Prostate Cancer, Renal Cyst
on May 17, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: adrenal adenoma, cyst, gastric cyst, oesophageal disorder, pancreatic pseudocyst, pancreatitis, prostate cancer (What is prostate cancer?), renal cyst. Glimepiride dosage: 6 Mg (6 Mg, 1 In 1 D), Oral. During the same period patient was treated with METFORMIN HCL (1000 Mg (500 Mg, 2 In 1 D), Oral) (View Metformin Hcl Review and Metformin Hcl Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6785796-6 | Hypoglycaemia
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Jun 15, 2010 from GERMANY Additional patient health information: Male patient , 76 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, hypercholesterolaemia, prophylaxis and. Glimepiride dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6784919-2 | Injury, Rib Fracture, Road Traffic Accident, Tibia Fracture
Adverse event was reported on Jun 10, 2010 by a Female patient taking Glimepiride (View Usage) (Dosage: 4 Mg, 1 In 1 D, Per Oral; 4 Mg, 1 In 1 D, Per Oral, 2 Mg, 2 In 1 D, Per Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 62 years of age, weighting 145.5 lb, Patient had the following side effects: injury, rib fracture, road traffic accident, tibia fracture. During the same period patient was treated with METFORMIN HCL (500 Mg, 2 In 1 D, Per Oral) (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DARVOCET N50MG (PROPACET) (View Darvocet N50mg (propacet) Review and Darvocet N50mg (propacet) Label ), LIALDA (View Lialda Review and Lialda Label ). Patient was hospitalized.

6784918-0 | Amnesia, Hypokalaemia, Metabolic Encephalopathy, Myoclonus, Treatment Noncompliance
on Jun 10, 2010 Male patient from UNITED STATES , 50 years of age, weighting 260.6 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: amnesia, hypokalaemia, metabolic encephalopathy, myoclonus, treatment noncompliance. Glimepiride dosage: 6 Mg, 1 In 1 D, Per Oral; 4 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6783274-1 | Cardiac Failure Congestive, Dyspnoea, Oedema, Weight Increased
on Jun 17, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, dyspnoea, oedema, weight increased. Glimepiride dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6763786-7 | Blood Glucose Increased, Blood Potassium Increased, Blood Pressure Systolic Increased, Blood Sodium Decreased, Blood Triglycerides Increased, Coronary Artery Disease, Diabetes Mellitus Inadequate Control, Dilatation Ventricular, Ejection Fraction Decreased
Patient was taking Glimepiride (View Usage). Patient had the following side effects: blood glucose increased, blood potassium increased, blood pressure systolic increased, blood sodium decreased, blood triglycerides increased, coronary artery disease (What is coronary artery disease?), diabetes mellitus inadequate control, dilatation ventricular, ejection fraction decreased on Jun 02, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 202.0 lb, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: 4 Mg, Oral; 4 Mg,oral. During the same period patient was treated with METFORMIN HCL (Oral; Oral) (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NORVASC (View Norvasc Review and Norvasc Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), EQUATE OMEPRAZOLE (OMEPRAZOLE) (View Equate Omeprazole (omeprazole) Review and Equate Omeprazole (omeprazole) Label ). Patient was hospitalized.

6763255-4 | Depressed Level Of Consciousness, Hypoglycaemia
Adverse event was reported on May 27, 2010 by a Female patient taking Glimepiride (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 80 years of age, After Glimepiride was administered, patient had the following side effects: depressed level of consciousness, hypoglycaemia. During the same period patient was treated with ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NATECAL D3 (View Natecal D3 Review and Natecal D3 Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6753356-9 | Blood Bilirubin Increased, Hepatic Enzyme Increased, Jaundice Cholestatic, Pancreatitis Acute
on May 28, 2010 Female patient from RUSSIAN FEDERATION , 61 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic enzyme increased, jaundice cholestatic, pancreatitis acute. Glimepiride dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6744233-8 | Back Pain, Metastases To Bone, Metastases To Liver, Metastases To Spine, Metastatic Neoplasm, Pulmonary Mass
on May 21, 2010 Male patient from UNITED KINGDOM , 69 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: back pain (What is back pain?), metastases to bone, metastases to liver, metastases to spine, metastatic neoplasm, pulmonary mass. Glimepiride dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6730506-1 | Accidental Exposure, Altered State Of Consciousness, Amnesia, Confusional State
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: accidental exposure, altered state of consciousness, amnesia, confusional state on May 06, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 260.6 lb, was diagnosed with diabetes mellitus and. Glimepiride dosage: 6 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with METFORMIN HCL (1000 Mg, 2 In 1 D, Per Oral) (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (HYDROCHLOROTHAIZIDE) (View Hydrochlorothiazide (hydrochlorothaizide) Review and Hydrochlorothiazide (hydrochlorothaizide) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6727792-0 | Cardiac Failure Congestive, Dyspnoea, Oedema, Weight Increased
Adverse event was reported on May 10, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, dyspnoea, oedema, weight increased. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6727729-4 | Arrhythmia, Sciatica
on May 07, 2010 Female patient from JAPAN , 76 years of age, weighting 106.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension, lipid metabolism disorder, insomnia, iliac artery occlusion and was treated with Glimepiride (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), sciatica (What is sciatica?). Glimepiride dosage: Dose As Used: 1 Tablet. During the same period patient was treated with ADALAT CC (Dose As Used: 1 Tablet Dose Unit: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), DIOVANE (Dose As Used: 1 Tablet Dose Unit: 40 Mg) (View Diovane Review and Diovane Label ), MEVALOTIN (Dose As Used: 1 Tablet) (View Mevalotin Review and Mevalotin Label ), MYSLEE (View Myslee Review and Myslee Label ), OPALMON (Dose As Used: 1 Tablet Dose Unit: 5 Ug) (View Opalmon Review and Opalmon Label ), MUCOSTA (Dose As Used: 1 Tablettid) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6726127-7 | Gastroenteritis, Nausea
on May 10, 2010 Female patient from SOUTH AFRICA , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?), nausea (What is nausea?). Glimepiride dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ACEBUTOLOL HYDROCHLORIDE (View Acebutolol Hydrochloride Review and Acebutolol Hydrochloride Label ). Patient was hospitalized.

6720077-8 | Back Pain
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?) on Apr 30, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6703286-3 | Decreased Appetite, Hypoglycaemic Unconsciousness, Pneumonia Aspiration
Adverse event was reported on Apr 23, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), hypertension and. Location: UNITED STATES , 68 years of age, weighting 132.3 lb, Patient had the following side effects: decreased appetite, hypoglycaemic unconsciousness, pneumonia aspiration. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6696743-X | Weight Increased
on Apr 16, 2010 Male patient from UNITED STATES , 63 years of age, weighting 263.9 lb, was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: weight increased. Glimepiride dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ).

6693803-4 | Acute Myocardial Infarction, Blood Glucose Increased, Blood Potassium Increased, Blood Sodium Decreased, Blood Triglycerides Increased, Coronary Artery Disease, Glycosylated Haemoglobin Increased, Haematocrit Decreased, Haemoglobin Decreased
on Apr 13, 2010 Male patient from UNITED STATES , 53 years of age, weighting 202.0 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood glucose increased, blood potassium increased, blood sodium decreased, blood triglycerides increased, coronary artery disease (What is coronary artery disease?), glycosylated haemoglobin increased, haematocrit decreased, haemoglobin decreased. Glimepiride dosage: 4 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with METFORMIN HCL (Per Oral) (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NORVAC (AMLODIPINE BESILATE) (View Norvac (amlodipine Besilate) Review and Norvac (amlodipine Besilate) Label ), MULTIVITAMIN (VIGRAN) (View Multivitamin (vigran) Review and Multivitamin (vigran) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6693026-9 | Bone Pain, Chills, Headache, Nausea, Oedema Peripheral, Stomatitis
Patient was taking Glimepiride (View Usage). Patient had the following side effects: bone pain, chills, headache (What is headache?), nausea (What is nausea?), oedema peripheral, stomatitis on Apr 09, 2010 from NETHERLANDS Additional patient health information: Female patient , 83 years of age, was diagnosed with diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with GLICLAZIDE 80 MG TABLETS (View Gliclazide 80 Mg Tablets Review and Gliclazide 80 Mg Tablets Label ).

6672686-2 | Cardiac Failure, Dyspnoea
Adverse event was reported on Apr 01, 2010 by a Male patient taking Glimepiride (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, After Glimepiride was administered, patient had the following side effects: cardiac failure, dyspnoea. During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6662266-7 | Prostate Cancer
on Mar 23, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with diabetes mellitus, hypertension, embolism and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?). Glimepiride dosage: . During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6658031-7 | Gastroenteritis, Nausea
on Mar 23, 2010 Female patient from SOUTH AFRICA , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?), nausea (What is nausea?). Glimepiride dosage: . During the same period patient was treated with METFORMIN (GLUCOPHAGE) (View Metformin (glucophage) Review and Metformin (glucophage) Label ). Patient was hospitalized.

6657663-X | Pancreatic Pseudocyst, Prostate Cancer
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: pancreatic pseudocyst, prostate cancer (What is prostate cancer?) on Mar 17, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with diabetes mellitus, hypertension, embolism and. Glimepiride dosage: 6 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with DILTIAZEM (60 Mg, 3 In 1 D, Per Oral) (View Diltiazem Review and Diltiazem Label ), FUROSEMIDE (40 Mg, 1 In 1 D, Per Oral) (View Furosemide Review and Furosemide Label ), POTASSIUM GLUCONATE TAB (550 Mg, 1 In 1 D, Per Oral) (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), FISH OIL (FISH OIL) (Per Oral) (View Fish Oil (fish Oil) Review and Fish Oil (fish Oil) Label ), WARFARIN SODIUM (10 Mg T, Th, F, And 20 Mg M, W, Sat) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6607048-7 | Blood Glucose Increased, Dizziness, Fluid Retention, Hypertension, Loss Of Consciousness, Wound Infection, Wound Secretion
Adverse event was reported on Feb 08, 2010 by a Female patient taking Glimepiride (View Usage) (Dosage: 4 Mg, 2 In 1 D, Per Oral) was diagnosed with diabetes mellitus, hypertension and. Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, dizziness (What is dizziness?), fluid retention, hypertension, loss of consciousness, wound infection, wound secretion. During the same period patient was treated with METFORMIN HCL (500 Mg, 2 In 1 D, Per Oral) (View Metformin Hcl Review and Metformin Hcl Label ), AVANDIA (4 Mg, 1 In 1 D, Per Oral) (View Avandia Review and Avandia Label ), LISINOPRIL (20 Mg, 1 In 1 D, Per Oral) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6600620-X | Diabetic Coma, Oedema Peripheral, Shock Hypoglycaemic
on Feb 23, 2010 Male patient from UNITED STATES , 87 years of age, weighting 121.9 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: diabetic coma, oedema peripheral, shock hypoglycaemic. Glimepiride dosage: . Patient was hospitalized.

6576531-5 | Adenocarcinoma Pancreas, Liver Function Test Abnormal
on Feb 02, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: adenocarcinoma pancreas, liver function test abnormal. Glimepiride dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6541667-1 | Adenocarcinoma Pancreas
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: adenocarcinoma pancreas on Jan 04, 2010 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6506907-3 | Arrhythmia, Sciatica
Adverse event was reported on Dec 16, 2009 by a Female patient taking Glimepiride (View Usage) (Dosage: Dose As Used: 1 Tablet) was diagnosed with type 2 diabetes mellitus, hypertension, lipid metabolism disorder, insomnia, iliac artery occlusion and. Location: JAPAN , 76 years of age, weighting 106.9 lb, Patient had the following side effects: arrhythmia (What is arrhythmia?), sciatica (What is sciatica?). During the same period patient was treated with ADALAT CC (Dose As Used: 1 Tablet Dose Unit: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), DIOVANE (Dose As Used: 1 Tablet Dose Unit: 40 Mg) (View Diovane Review and Diovane Label ), MEVALOTIN (Dose As Used: 1 Tablet) (View Mevalotin Review and Mevalotin Label ), MYSLEE (Dose As Used: 1 Tablet) (View Myslee Review and Myslee Label ), OPALMON (Dose As Used: 1 Tablet Dose Unit: 5 Ug) (View Opalmon Review and Opalmon Label ), MUCOSTA (Dose As Used: 1 Tablettid) (View Mucosta Review and Mucosta Label ), PALUX (Dose As Used: 2 Ml Dose Unit: 10 Ug) (View Palux Review and Palux Label ). Patient was hospitalized.

6503137-6 | Hypersensitivity
on Jan 26, 2009 Male patient from UNITED STATES , 50 years of age, was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: hypersensitivity. Glimepiride dosage: Oral. Patient was hospitalized.

6502877-2 | Hypoaesthesia
on Nov 23, 2009 Male patient from UNITED KINGDOM , 49 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia. Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6492611-7 | Decreased Appetite, Hepatic Cancer Stage Iv, Pallor, Yellow Skin
Patient was taking Glimepiride (View Usage). Patient had the following side effects: decreased appetite, hepatic cancer stage iv, pallor, yellow skin on Dec 03, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, . Glimepiride dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.